Law firm · India

Cyril Amarchand Mangaldas

Deals
2
Latest
Apr 2026
Compare

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deal size
Custom range

2 of 2 deals

Deals Cyril Amarchand Mangaldas advised on, most recent first
Advisers
Apr 2026 Organon & Co. –Sun Pharmaceutical IndustriesAcquisitionLegal adviser to Organon (target)Announced11,750.0Pharma J.P. Morgan (buy-side)Jefferies (buy-side)White & Case (buy-side)AZB & Partners (buy-side)Morgan Stanley (sell-side)Goldman Sachs (sell-side)Sullivan & Cromwell (sell-side) Sun Pharmaceutical Industries acquisition of Organon & Co.
Apr 2026 TruBridge –Inventurus Knowledge SolutionsAcquisitionLegal adviser to TruBridge (target)Announced–Healthcare Software+1 Solomon Partners (sell-side)Sullivan & Cromwell (sell-side)Maynard Nexsen (sell-side)J.P. Morgan (buy-side)Citi (buy-side)Katten Muchin Rosenman (buy-side)Shardul Amarchand Mangaldas & Co (buy-side)Willkie Farr & Gallagher (sell-side) Inventurus Knowledge Solutions acquisition of TruBridge

Offices and contact

Contact

From the firm's own website.

Suggest a correction

A missing deal, a wrong role or an office to add. A link to a public source helps.